Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis

Fig. 1

Study design. aThe follow-up ends at the earliest occurrence of the outcome, or at inpatient death, disenrollment, a maximum of 360 days, or the end of the study period. COPD chronic obstructive pulmonary disorder, ICS inhaled corticosteroid, LABA long-acting β2-agonist, LAMA long-acting muscarinic antagonist, Tio tiotropium, Tio/Olo tiotropium/olodaterol

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us